A bitter Congressional fight over the cost of superexpensive biotechnology drugs has come down to a single, hotly debated number: How many years should makers of those drugs be exempt from generic competition?
As the editor of Wired magazine and a champion of the online life, you have just written a controversial book, “Free: The Future of a Radical Price,” that suggests that companies can profit by giving away digital services and products.
I AM in Stockholm, with a group of Brussels-based journalists invited to meet the Swedish government, a day before Sweden takes over the rotating presidency of the European Union. The change of pace and mood could not be more dramatic. I have been coming to Sweden since the 1980s, and very regularly in the last ten years. The place never fails to impress: Stockholm combines extraordinary efficiency and organisation with a healthily relaxed view of life, plus a strong tang of the sea. It is a bit like crossing Zurich with Sydney.